| Net Cash Provided by (Used in) Operating Activities |
$400,000 |
USD |
-99% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$21,800,000 |
USD |
211% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$29,200,000 |
USD |
12% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
65,992,259 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
60,992,259 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$61,200,000 |
USD |
37% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$67,300,000 |
USD |
33% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$159,600,000 |
USD |
6.5% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability |
$43,500,000 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$72,500,000 |
USD |
-611% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$52,800,000 |
USD |
29% |
Q4 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$8,200,000 |
USD |
-15% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$6,500,000 |
USD |
23% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$10,000,000 |
USD |
-6.5% |
Q4 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.057 |
pure |
1.8% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$9,300,000 |
USD |
90% |
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
$5,600,000 |
USD |
27% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$59,500,000 |
USD |
10% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$4,700,000 |
USD |
|
Q4 2025 |
FY 2025 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
$5,100,000 |
USD |
34% |
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$80,200,000 |
USD |
-5.3% |
Q4 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$131,900,000 |
USD |
5.3% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$92,300,000 |
USD |
-7% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$48,400,000 |
USD |
3.6% |
Q1 2024 |
Q1 2024 |